Minsky B D, Enker W E, Cohen A M, Lauwers G
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021.
Am J Clin Oncol. 1994 Oct;17(5):411-6. doi: 10.1097/00000421-199410000-00011.
We report the results of 22 patients with localized, mobile, resectable rectal cancer treated with local excision and postoperative radiation therapy.
Margins were negative in 21 patients and unassessable in 1. The median follow-up was 37 months (range: 5-73 months). The median tumor size was 3.0 cm (range: 1-6.2 cm). Full-thickness local excisions were performed in 21 patients: transanal, 11; transsphincteric, 2; and posterior proctotomy (Kraske), 8. All margins were inked and were microscopically negative in 21. One patient had a transanal snare excision of a T1 polyp. Postoperatively patients received 4,500-4,950 cGy (median: 4,680 cGy) whole pelvis, and in 15 this was followed by a conedown to 360-1,000 cGy (median: 360 cGy).
The 4-year actuarial survival was 79% and the 4-year actuarial colostomy-free survival was 73%. The incidence of local failure was 18% and increased with T stage: T1: 0/4 (0%); T2: 2/12 (17%); and T3: 2/6 (33%). Four patients developed local failure at 6, 10, 15, and 21 months. Of the four, three underwent salvage APR and were locally controlled at 6, 33, and 58 months following salvage surgery. The incidence of abdominal failure was 18% and distant failure was 18%. Of the 15 eligible patients, 14 (93%) had good or excellent sphincter function.
The results of local excision and postoperative radiation therapy are encouraging; however, more experience is needed to determine if this approach ultimately has similar local control and survival rates as standard surgery.
我们报告了22例接受局部切除及术后放疗的局限性、可移动、可切除直肠癌患者的治疗结果。
21例患者切缘阴性,1例切缘无法评估。中位随访时间为37个月(范围:5 - 73个月)。肿瘤中位大小为3.0 cm(范围:1 - 6.2 cm)。21例患者进行了全层局部切除:经肛门切除11例;经括约肌切除2例;后位直肠切开术(克拉斯克手术)8例。所有切缘均标记墨水,21例显微镜下切缘阴性。1例患者经肛门圈套切除T1期息肉。术后患者接受全盆腔4500 - 4950 cGy(中位剂量:4680 cGy)放疗,其中15例随后缩野至360 - 1000 cGy(中位剂量:360 cGy)。
4年精算生存率为79%,4年无结肠造口精算生存率为73%。局部失败发生率为18%,并随T分期增加:T1期:0/4(0%);T2期:2/12(17%);T3期:2/6(33%)。4例患者分别在6、10、15和21个月出现局部失败。其中3例接受挽救性腹会阴联合切除术,挽救性手术后6、33和58个月局部得到控制。腹部失败发生率为18%,远处失败发生率为18%。15例符合条件的患者中,14例(93%)括约肌功能良好或优秀。
局部切除及术后放疗的结果令人鼓舞;然而,需要更多经验来确定这种方法最终是否具有与标准手术相似的局部控制率和生存率。